This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement.
This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:
Butterly Medical
Endotherapeutics
Olympus
ProArc
ProVerum
Teleflex
Urotronic
ZenFlow